Kwang Dong Pharm Co Ltd in Soft Drinks (South Korea)

August 2014 | 3 pages | ID: K4C8ACEEF71EN
Euromonitor International Ltd

Abstracts

At the end of the review period health-oriented beverages represented over 50% of total company revenues due to the rapid growth of its major brands, such as Kwangdong Oriental Raisin Tea. As the company's base is in pharmaceutical products, it plans to increase its key capacities in R&D and its sales network to strengthen its competitive edge in all of its business areas.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Asian Speciality Drinks, Bottled Water, Carbonates, Concentrates, Juice, RTD Coffee, RTD Tea, Sports and Energy Drinks.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Soft Drinks market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
Summary 1 Kwang Dong Pharmaceutical Co Ltd: Key Facts
Summary 2 Kwang Dong Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Summary 3 Kwang Dong Pharmaceutical Co Ltd: Production Statistics 2013
Competitive Positioning
Summary 4 Kwang Dong Pharmaceutical Co Ltd: Competitive Position 2013